Why is Sotac Pharma. falling/rising?

As of 09-Oct, Sotac Pharmaceuticals Ltd is experiencing a price increase, currently at 125.00, reflecting a rise of 5.85 or 4.91%. The stock has shown strong performance recently, with a one-week return of +15.63%, significantly outperforming the Sensex, which only increased by 1.39%. However, despite today's positive movement, there are concerns regarding falling investor participation, as the delivery volume has decreased by 28.57% compared to the five-day average. The stock is currently above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average. Additionally, while the stock has generated a negative return of -4.36% over the past year, its operating profit has grown significantly, leading to a favorable PEG ratio of 0.4, indicating attractive valuation metrics.
In the broader market context, Sotac Pharmaceuticals' recent short-term performance has been notably strong compared to the benchmark, as it has outperformed the Sensex in the past week. The stock's year-to-date return of +14.36% also contrasts with the Sensex's +6.50%, showcasing its resilience in a fluctuating market. This outperformance, combined with healthy long-term growth indicators such as a 40.49% annual increase in operating profit and a return on capital employed (ROCE) of 5.7, suggests that the stock is positioned well despite recent volatility. Overall, the combination of strong short-term gains and solid fundamentals contributes to the stock's upward movement.